Yangwei Xu
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cell death mechanisms and regulation 1
- RNA Interference and Gene Delivery 1
-
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Qingling Zhang (10 shared papers)Guifang Zhu (6 shared papers)Huilin Niu (1 shared paper)Deying Liu (1 shared paper)Jiahui Xu (1 shared paper)Jian Li (1 shared paper)Jingbo Sun (6 shared papers)Yun Fu (4 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)iScience (2 papers)JAMA Surgery (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yangwei Xu
9 papers receiving 454 citations
Peers
Comparison fields: 5 of 62
- Geriatrics and Gerontology 56
- Cancer Research 106
- Applied Microbiology and Biotechnology 8
- Oncology 78
- Pathology and Forensic Medicine 49
Countries citing papers authored by Yangwei Xu
This map shows the geographic impact of Yangwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangwei Xu more than expected).
Fields of papers citing papers by Yangwei Xu
This network shows the impact of papers produced by Yangwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangwei Xu. The network helps show where Yangwei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 228 | |
| 2 | 2017 | 110 | |
| 3 | 2020 | 43 | |
| 4 | 2020 | 35 | |
| 5 | 2021 | 23 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 5 | |
| 8 | 2024 | 3 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 | |
| 12 | 2021 | 0 |
About Yangwei Xu
Yangwei Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 12 papers that have together received 454 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Ferroptosis and cancer prognosis (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Chemokine receptors and signaling (1 paper), Cell death mechanisms and regulation (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Geriatrics and Gerontology (56 citations), Cancer Research (106 citations), Applied Microbiology and Biotechnology (8 citations), Oncology (78 citations) and Pathology and Forensic Medicine (49 citations). Yangwei Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qingling Zhang, Guifang Zhu, Huilin Niu, Deying Liu, Jiahui Xu, Jian Li, Jingbo Sun, Yun Fu, Zhen Han and Shuguang Zhu. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, iScience, JAMA Surgery, Frontiers in Cell and Developmental Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.